{
    "organizations": [],
    "uuid": "0b07efb5660b867abecd9cb88a2abee5bf4278e9",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-brightpath-biotherapeutics-says-ex/brief-brightpath-biotherapeutics-says-exercise-of-options-idUSL3N1PA2FF",
    "ord_in_thread": 0,
    "title": "BRIEF-BrightPath Biotherapeutics says exercise of options",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 15 (Reuters) - BrightPath Biotherapeutics Co Ltd :\n* Says 15,000 units of its 12th series options were exercised to 1.5 million shares of its common stock, at price of 757 yen per share, on Jan. 15\nSource text in Japanese: goo.gl/W4jktq\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-01-15T14:24:00.000+02:00",
    "crawled": "2018-01-16T13:36:08.011+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "brightpath",
        "biotherapeutics",
        "co",
        "ltd",
        "say",
        "unit",
        "12th",
        "series",
        "option",
        "exercised",
        "million",
        "share",
        "common",
        "stock",
        "price",
        "yen",
        "per",
        "share",
        "source",
        "text",
        "japanese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}